Margaret Kielian

Title: Innovations and Contributions of Inventor Margaret Kielian

Introduction

Margaret Kielian is a prominent inventor based in Pelham, NY (US), known for her significant contributions to the field of virology. With a total of three patents to her name, she has made remarkable strides in developing treatments for viral infections, particularly those caused by alphaviruses and Dengue virus.

Latest Patents

Kielian's latest patents include groundbreaking work on antibodies or antibody-fragments targeting alphaviruses. These high-affinity anti-alphavirus antibodies and their fragments are designed for use in various medical applications, including methods for treating different types of alphavirus infections. Another notable patent focuses on specific Dengue virus glycoprotein E DIII variants, which are crucial for preventing and treating Dengue virus infections.

Career Highlights

Margaret Kielian is affiliated with the Albert Einstein College of Medicine, where she conducts her research and develops her innovative solutions. Her work has garnered attention in the scientific community, contributing to advancements in the understanding and treatment of viral diseases.

Collaborations

Kielian collaborates with esteemed colleagues, including Jonathan R Lai and Jose Quiroz, to further her research and enhance the impact of her inventions.

Conclusion

Margaret Kielian's contributions to the field of virology through her patents and research at the Albert Einstein College of Medicine highlight her role as a leading inventor in the fight against viral infections. Her innovative work continues to pave the way for new treatments and therapies.